In contrast to that in NSCLC, PD-L1 expression in other cancers such as head and neck squamous cell carcinoma is scored using the combined positive score (CPS), which encompasses PD-L1 expression on both tumor cells and immune cells in the tumor microenvironment [25]. This evidence concerns the gene CD274 and cancer.